Survival:?
Toxicity Grade:4
Treatments:Chemotherapy
Drugs:Doxil
Country:United States
City/State/Province:Minneapolis, Minnesota
Hospital:University of Minnesota Medical School
Journal:Link
Date:1/2002
Description:
Patients: This Phase II study involved 15 patients with mesothelioma.

Treatment: The treatment consisted of the administration of the drug, doxorubicin (doxil).

Toxicity: Toxicities included neutrophils (grade 3 and 4), skin (grade 1 and 2), mucositis (grade 1 and 2), nausea (grade 1), and fatigue (grade 1).

Results: One patient had a partial response. Overall survival was not discussed.